Esmat Abdi

472 total citations
22 papers, 332 citations indexed

About

Esmat Abdi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Esmat Abdi has authored 22 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Esmat Abdi's work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (9 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Esmat Abdi is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (9 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Esmat Abdi collaborates with scholars based in Iran and France. Esmat Abdi's co-authors include Saeid Latifi‐Navid, Abbas Yazdanbod, Saber Zahri, Farhad Pourfarzi, Reza Safaralizadeh, Fatemeh Abdi, Rabah Boukherroub, Hamed Mazhab Jafari, Roxana Jijie and Julie Bouckaert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biosensors and Bioelectronics.

In The Last Decade

Esmat Abdi

21 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esmat Abdi Iran 11 195 171 110 53 36 22 332
Hui-Juan Su China 7 198 1.0× 194 1.1× 87 0.8× 36 0.7× 8 0.2× 8 337
Rebekah Engel Australia 6 58 0.3× 53 0.3× 27 0.2× 24 0.5× 37 1.0× 12 206
Kentaroh Yamamoto Japan 7 69 0.4× 88 0.5× 138 1.3× 71 1.3× 22 0.6× 12 389
Sonya Hessey United Kingdom 5 62 0.3× 38 0.2× 232 2.1× 58 1.1× 39 1.1× 7 400
Yongyong Lu China 9 189 1.0× 144 0.8× 23 0.2× 25 0.5× 11 0.3× 20 256
Deming Li China 9 94 0.5× 50 0.3× 109 1.0× 145 2.7× 8 0.2× 15 305
Tirosh Shapira Canada 8 211 1.1× 168 1.0× 128 1.2× 19 0.4× 21 0.6× 12 396
Zhaohui Ge China 10 172 0.9× 141 0.8× 181 1.6× 17 0.3× 29 0.8× 35 432

Countries citing papers authored by Esmat Abdi

Since Specialization
Citations

This map shows the geographic impact of Esmat Abdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmat Abdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmat Abdi more than expected).

Fields of papers citing papers by Esmat Abdi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esmat Abdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmat Abdi. The network helps show where Esmat Abdi may publish in the future.

Co-authorship network of co-authors of Esmat Abdi

This figure shows the co-authorship network connecting the top 25 collaborators of Esmat Abdi. A scholar is included among the top collaborators of Esmat Abdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esmat Abdi. Esmat Abdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdi, Esmat, et al.. (2025). The metabolic and immunomodulatory functions of Bacteroides fragilis; a next-generation probiotic?. SHILAP Revista de lepidopterología. 25. 100137–100137. 3 indexed citations
2.
Abdi, Esmat, et al.. (2024). Roles of the lncRNAs MEG3, PVT1 and H19 tagSNPs in gastric cancer susceptibility. BMC Cancer. 24(1). 1440–1440.
3.
Abdi, Esmat & Saeid Latifi‐Navid. (2023). Long Noncoding RNA Polymorphisms and Hepatocellular Carcinoma and Pancreatic Cancer Risk. Personalized Medicine. 20(2). 193–200. 3 indexed citations
4.
Abdi, Esmat, et al.. (2023). Risk of Gastric Cancer is Highly Dependent on Type of First-Degree Family Member Affected by Cancer: Lessons from a High-Risk Population in Iran. Iranian Journal of Public Health. 52(9). 2004–2013. 1 indexed citations
5.
Abdi, Esmat, et al.. (2023). LncRNA Polymorphisms and Lung Cancer Risk. Personalized Medicine. 20(6). 511–522. 7 indexed citations
6.
Abdi, Esmat, et al.. (2023). Long Noncoding RNA Polymorphisms in Gynecological Cancers. Personalized Medicine. 21(1). 59–68. 5 indexed citations
7.
Abdi, Esmat & Saeid Latifi‐Navid. (2022). Emerging long noncoding RNA polymorphisms as novel predictors of survival in cancer. Pathology - Research and Practice. 239. 154165–154165. 10 indexed citations
8.
Abdi, Esmat, et al.. (2022). Long noncoding RNA polymorphisms and colorectal cancer risk: Progression and future perspectives. Environmental and Molecular Mutagenesis. 63(2). 98–112. 8 indexed citations
9.
Abdi, Esmat & Saeid Latifi‐Navid. (2022). LncRNA polymorphisms and urologic cancer risk. Environmental and Molecular Mutagenesis. 63(4). 190–203. 10 indexed citations
10.
Abdi, Esmat, et al.. (2021). LncRNA polymorphisms and breast cancer risk. Pathology - Research and Practice. 229. 153729–153729. 19 indexed citations
11.
Abdi, Esmat, et al.. (2021). Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opinion on Therapeutic Targets. 25(8). 685–699. 17 indexed citations
12.
Abdi, Esmat, et al.. (2021). Interaction between lncRNAs HOTAIR and MALAT1 tagSNPs in gastric cancer. British Journal of Biomedical Science. 78(3). 147–150. 13 indexed citations
13.
Abdi, Esmat, et al.. (2021). Novel long intergenic non-coding RNA—AC064834.1—Misregulation in gastric cancer. Gene Reports. 24. 101256–101256. 4 indexed citations
14.
Abdi, Esmat, et al.. (2020). LncRNA polymorphisms and upper gastrointestinal cancer risk. Pathology - Research and Practice. 218. 153324–153324. 19 indexed citations
15.
Abdi, Esmat, et al.. (2020). SNP-SNP interactions of oncogenic long non-coding RNAs HOTAIR and HOTTIP on gastric cancer susceptibility. Scientific Reports. 10(1). 16763–16763. 24 indexed citations
16.
Abdi, Esmat, et al.. (2020). Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers. Expert Review of Molecular Diagnostics. 20(11). 1121–1138. 28 indexed citations
17.
Abdi, Esmat, Saeid Latifi‐Navid, Saber Zahri, Abbas Yazdanbod, & Farhad Pourfarzi. (2019). Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives. Cancer Medicine. 8(13). 6114–6126. 72 indexed citations
18.
Jafari, Hamed Mazhab, Mandana Amiri, Esmat Abdi, et al.. (2018). Entrapment of uropathogenic E. coli cells into ultra-thin sol-gel matrices on gold thin films: A low cost alternative for impedimetric bacteria sensing. Biosensors and Bioelectronics. 124-125. 161–166. 38 indexed citations
19.
Abdi, Esmat, Saeid Latifi‐Navid, Saber Zahri, Abbas Yazdanbod, & Reza Safaralizadeh. (2017). Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran. Microbial Pathogenesis. 107. 287–292. 22 indexed citations
20.
Abdi, Esmat, Saeid Latifi‐Navid, Abbas Yazdanbod, & Saber Zahri. (2016). Helicobacter pylori babA2 Positivity Predicts Risk of Gastric Cancer in Ardabil, a Very High-Risk Area in Iran. Asian Pacific Journal of Cancer Prevention. 17(2). 733–738. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026